LitigationUSA
No claim to damages for Millenium and Cilag in dispute over bortezomib
Millennium Pharma and its distributor Cilag are not eligible to receive damages from generic companies for the infringement of patents related to anti-cancer medication Velcade. The Regional Court Düsseldorf dismissed t…
Tuesday, April 28, 2026